Quantcast

Latest Attention-deficit hyperactivity disorder controversies Stories

2010-10-04 23:28:10

Young children with attention-deficit/hyperactivity disorder (ADHD) appear to be at greater risk for adolescent depression and/or suicide attempts five to 13 years after diagnosis, according to a report in the October issue of Archives of General Psychiatry, one of the JAMA/Archives journals. Sixteen to 37 percent of clinically-diagnosed adults with attention-deficit/hyperactivity disorder also suffer from major depressive disorder and/or dysthymia (a mild form of depression). "When major...

2010-10-04 23:05:15

Children diagnosed with attention deficit/hyperactivity disorder (ADHD) at ages 4 to 6 are more likely to suffer from depression as adolescents than those who did not have ADHD at that age, according to a long-term study published in the October issue of the Archives of General Psychiatry. Although it was an uncommon occurrence, the children with ADHD also were somewhat more likely to think about or attempt suicide as adolescents. "This study is important in demonstrating that, even during...

2010-10-04 19:38:04

When girls with symptoms of autism or ADHD seek professional medical help, their problems are often played down or misinterpreted, and there is a real risk that they will not get the help or support they need. As such, more training is needed in this area, particularly in the public sector, reveals a thesis from the University of Gothenburg. The thesis focuses primarily on 100 girls who, before reaching adulthood, went to the doctor on account of difficulties with social interaction and/or...

2010-10-04 07:00:00

FLORHAM PARK, N.J., Oct. 4 /PRNewswire/ -- Shionogi Inc., the U.S.-based group company of Shionogi & Co., Ltd., today announced the U.S. Food and Drug Administration approval of the non-stimulant medication KAPVAY(TM) (clonidine hydrochloride) extended-release tablets, an extended-release oral formulation for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents ages 6-17 years. KAPVAY(TM) is the only formulation of clonidine hydrochloride approved...

6b477bdc6df88537260f72750813883a1
2010-09-30 09:30:00

Scientists at the UK's Cardiff University report they have discovered evidence that attention-deficit/hyperactivity disorder (ADHD) is a genetic condition--a discovery that could help find better ways to treat the ailment and exonerate parents often blamed for poor child rearing. Writing in the medical journal The Lancet, Dr. Nigel M. Williams of the Cardiff School of Medicine and his colleagues found that children who were diagnosed with ADHD were more likely to have small segments of their...

2010-09-16 07:30:00

Briefing hosted by Shire, the Entertainment Industries Council and the Lab School of Washington with actress Roxy Olin delivering keynote on behalf of Entertainment Industries Council as part of its mental health advocacy tour WASHINGTON, Sept. 16 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, has partnered with the Entertainment Industries Council (EIC) , the Lab School of Washington and other organizations in support of...

2010-09-14 12:35:16

Trial led by St. Jude Children's Research Hospital investigators finds medication restores sustained attention of many young survivors; work begins on new strategies to help survivors cope with this common challenge A medicine widely used to treat attention-deficit/hyperactivity disorder (ADHD) also provides long-term relief from the attention and behavior changes that affect many childhood cancer survivors, according to a multicenter trial led by St. Jude Children's Research Hospital...

2010-09-08 17:27:00

Actress Roxy Olin delivers keynote on behalf of Entertainment Industries Council as part of mental health advocacy tour WASHINGTON, Sept. 8 /PRNewswire-USNewswire/ -- The following was released today by Shire: WHAT: Though an estimated 4.5 million Americans suffer from Attention Deficit Hyperactivity Disorder (ADD/ADHD), few understand the realities of the illness and the day-to-day challenges that it presents for those who live with it. To coincide with ADD/ADHD Awareness Week,...

2010-09-08 14:54:00

Persistent myths about Attention-Deficit/Hyperactivity Disorder damage public perception of the 4% to 9% of the population grappling with this devastating condition. The nation's four leading ADHD organizations seek to end the stigma, once and for all. NEW YORK, Sept. 8/PRNewswire-USNewswire/ -- Four national organizations - ADHD Coaches Organization (ACO); Attention Deficit Disorder Association (ADDA); ADDitude magazine; and Children and Adults with Attention-Deficit/Hyperactivity...

2010-08-27 08:14:07

(Ivanhoe Newswire) -- Adults with attention-deficit/hyperactive disorder (ADHD) are showing greater improvement when receiving individual sessions of cognitive behavioral therapy (CBT) in addition to their monthly medication. "Approximately 4.4 percent of adults in the United States with ADHD, which is a disorder characterized by impairing levels of inattention, hyperactivity, and impulsivity. Medications have been the primary treatment; however, many adults with ADHD cannot or will not take...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related